{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=formoterol+fumarate+inhalation+solution", "query": { "intervention": "formoterol fumarate inhalation solution" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 34, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=formoterol+fumarate+inhalation+solution&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-27T01:40:56.184Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT04320342", "title": "A Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "COPD", "COPD Exacerbation" ], "interventions": [ { "name": "Beclomethasone Dipropionate", "type": "DRUG" }, { "name": "Glycopyrronium Bromide", "type": "DRUG" }, { "name": "Formoterol Fumarate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Chiesi Farmaceutici S.p.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 3406, "start_date": "2022-04-27", "completion_date": "2026-01-12", "has_results": false, "last_update_posted_date": "2026-09-21", "last_synced_at": "2026-09-27T01:40:56.184Z", "location_count": 276, "location_summary": "Birmingham, Alabama • Dothan, Alabama • Foley, Alabama + 178 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Dothan", "state": "Alabama" }, { "city": "Foley", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT04320342" }, { "nct_id": "NCT07721922", "title": "Efficacy of Nebulized Long-Acting Bronchodilators (Formoterol and Revefenacin) vs. Short-Acting Bronchodilators (Albuterol and Ipratropium) in Patients Presenting to the Emergency Department With Acute Exacerbation of COPD (ECOPD)", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "COPD Exacerbation" ], "interventions": [ { "name": "Revefenacin", "type": "DRUG" }, { "name": "formoterol fumarate", "type": "DRUG" }, { "name": "Placebo (Sterile Normal Saline)", "type": "OTHER" }, { "name": "Albuterol sulfate", "type": "DRUG" }, { "name": "Ipratropium Bromide", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Tennessee Graduate School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 280, "start_date": "2026-09-01", "completion_date": "2028-09-01", "has_results": false, "last_update_posted_date": "2026-08-17", "last_synced_at": "2026-09-27T01:40:56.184Z", "location_count": 1, "location_summary": "Knoxville, Tennessee", "locations": [ { "city": "Knoxville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT07721922" }, { "nct_id": "NCT02291016", "title": "COPD Aerosol Study Comparing the Efficacy of Nebulizers Versus Dry Powder Inhalers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "COPD Exacerbation" ], "interventions": [ { "name": "Formoterol", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "University of Tennessee Graduate School of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 7, "start_date": "2015-02", "completion_date": "2016-03", "has_results": true, "last_update_posted_date": "2019-03-19", "last_synced_at": "2026-09-27T01:40:56.184Z", "location_count": 1, "location_summary": "Knoxville, Tennessee", "locations": [ { "city": "Knoxville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT02291016" }, { "nct_id": "NCT01854047", "title": "An Evaluation of Dupilumab in Patients With Moderate to Severe Uncontrolled Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Dupilumab", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "ICS/LABA therapy", "type": "DRUG" }, { "name": "Salbutamol/albuterol", "type": "DRUG" }, { "name": "Levosalbutamol/levalbuterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 776, "start_date": "2013-06", "completion_date": "2015-04", "has_results": true, "last_update_posted_date": "2017-06-26", "last_synced_at": "2026-09-27T01:40:56.184Z", "location_count": 50, "location_summary": "Fullerton, California • Huntington Beach, California • Los Angeles, California + 38 more", "locations": [ { "city": "Fullerton", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01854047" }, { "nct_id": "NCT00909779", "title": "Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Arformoterol", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 841, "start_date": "2009-06", "completion_date": "2012-06", "has_results": true, "last_update_posted_date": "2013-11-11", "last_synced_at": "2026-09-27T01:40:56.184Z", "location_count": 73, "location_summary": "Birmingham, Alabama • Brimingham, Alabama • Jasper, Alabama + 61 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Brimingham", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00909779" }, { "nct_id": "NCT00250679", "title": "Safety and Efficacy of Arformoterol Tartrate Inhalation Solution in Subjects With Chronic Obstructive Pulmonary Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Obstructive Pulmonary Disease", "Bronchitis", "Emphysema" ], "interventions": [ { "name": "Arformoterol tartrate inhalation solution", "type": "DRUG" }, { "name": "Arformoterol 25 ųg BID", "type": "DRUG" }, { "name": "Formoterol 12 ųg BID", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": null, "sex": "ALL", "summary": "35 Years and older" }, "enrollment_count": 443, "start_date": "2005-10", "completion_date": "2007-10", "has_results": true, "last_update_posted_date": "2012-06-04", "last_synced_at": "2026-09-27T01:40:56.184Z", "location_count": 60, "location_summary": "Birmingham, Alabama • Jasper, Alabama • Mobile, Alabama + 56 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Carmichael", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00250679" }, { "nct_id": "NCT00685529", "title": "Study of Arformoterol Tartrate Inhalation Solution and Racemic Formoterol in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "COPD" ], "interventions": [ { "name": "Racemic formoterol", "type": "DRUG" }, { "name": "Arformoterol tartrate inhalation solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "35 Years", "maximum_age": null, "sex": "ALL", "summary": "35 Years and older" }, "enrollment_count": 24, "start_date": "2005-04", "completion_date": "2005-10", "has_results": false, "last_update_posted_date": "2012-02-22", "last_synced_at": "2026-09-27T01:40:56.184Z", "location_count": 6, "location_summary": "Long Beach, California • Fort Lauderdale, Florida • Raleigh, North Carolina + 3 more", "locations": [ { "city": "Long Beach", "state": "California" }, { "city": "Fort Lauderdale", "state": "Florida" }, { "city": "Raleigh", "state": "North Carolina" }, { "city": "Simpsonville", "state": "South Carolina" }, { "city": "Spartanburg", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00685529" }, { "nct_id": "NCT06676319", "title": "Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Lunsekimig", "type": "DRUG" }, { "name": "Short-Acting Beta Agonists (SABA)", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Fluticasone/Salmeterol", "type": "DRUG" }, { "name": "Budesonide/Formoterol", "type": "DRUG" }, { "name": "Budesonide/Albuterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 556, "start_date": "2024-11-07", "completion_date": "2027-07-19", "has_results": false, "last_update_posted_date": "2026-09-22", "last_synced_at": "2026-09-27T01:40:56.184Z", "location_count": 53, "location_summary": "Saraland, Alabama • Chandler, Arizona • Sun City, Arizona + 47 more", "locations": [ { "city": "Saraland", "state": "Alabama" }, { "city": "Chandler", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06676319" }, { "nct_id": "NCT00571428", "title": "Efficacy Safety Study of Arformoterol QD Dosing Versus BID Dosing in COPD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Chronic Obstructive Pulmonary Disease" ], "interventions": [ { "name": "Arformoterol Tartrate Inhalation Solution", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": null, "sex": "ALL", "summary": "45 Years and older" }, "enrollment_count": 33, "start_date": "2007-11", "completion_date": "2008-03", "has_results": true, "last_update_posted_date": "2012-02-22", "last_synced_at": "2026-09-27T01:40:56.184Z", "location_count": 4, "location_summary": "Medford, Oregon • Portland, Oregon • Philadelphia, Pennsylvania + 1 more", "locations": [ { "city": "Medford", "state": "Oregon" }, { "city": "Portland", "state": "Oregon" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Spartanburg", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT00571428" }, { "nct_id": "NCT00308191", "title": "A Phase IIIB Study to Compare the Efficacy and Safety of Concomitant Treatment in Patients With COPD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "COPD" ], "interventions": [ { "name": "Formoterol Fumarate", "type": "DRUG" }, { "name": "Tiotropium Bromide", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Dey", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 128, "start_date": "2006-04", "completion_date": "2006-12", "has_results": false, "last_update_posted_date": "2008-03-07", "last_synced_at": "2026-09-27T01:40:56.184Z", "location_count": 17, "location_summary": "Phoenix, Arizona • Los Angeles, California • Sepulveda, California + 14 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Sepulveda", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00308191" } ] }